Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.
Financial Results:
Morepen Laboratories Ltd reported Revenues for Q1FY24 of ₹401.00 Crores up from ₹302.00 Crore year on year, a rise of 32.78%.
Total Expenses for Q1FY24 of ₹383.00 Crores up from ₹295.00 Crores year on year, a rise of 29.83%.
Consolidated Net Profit of ₹15.00 Crores up 150.0% from ₹6.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹0.29, up 163.64% from ₹0.11 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.